iex-20220615
0000832101false00008321012022-06-152022-06-15

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of report: June 15, 2022
(Date of earliest event reported)
IDEX CORPORATION
(Exact name of registrant as specified in its charter)
Delaware1-1023536-3555336
(State or other jurisdiction (Commission File Number)(IRS Employer
of incorporation)Identification No.)
3100 Sanders Road, Suite 301
Northbrook, Illinois 60062
(Address of principal executive offices, including zip code)
(847498-7070
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock, par value $.01 per shareIEXNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 15, 2022, the Board of Directors (the “Board”) of IDEX Corporation (the “Company”) appointed Alejandro Quiroz Centeno to serve as a member of the Board and as a member of the Compensation Committee of the Board, effective immediately, increasing the size of the Board from 10 to 11 members.

Mr. Quiroz has no familial relationships or related party transactions with the Company that would require disclosure under Items 401(d) or 404(a) of Regulation S-K in connection with his appointment described above. Mr. Quiroz was not selected pursuant to any arrangement or understanding between him and any other person.

Mr. Quiroz will participate in the compensation arrangements for non-employee members of the Board described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on March 23, 2022.

Item 9.01.     Financial Statements and Exhibits.

(a)Exhibits

99.1    Press Release dated June 16, 2022

104    Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IDEX CORPORATION
By:/s/  WILLIAM K. GROGAN
William K. Grogan
Senior Vice President and Chief Financial Officer
June 16, 2022



EXHIBIT INDEX
Exhibit
Number
Description
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

Document
https://cdn.kscope.io/3b7cba8c930a9ba618524f2b9bd7e2f6-image_0.jpg

Exhibit 99.1

IDEX Corporation Announces Appointment of Alejandro Quiroz Centeno to Board of Directors

NORTHBROOK, IL (June 16, 2022) – IDEX Corporation (NYSE:IEX) today announced the appointment of Alejandro Quiroz Centeno to the company’s Board of Directors. The appointment of Mr. Quiroz, effective June 15, 2022, increases the size of the board from 10 to 11 directors. He will serve on the board’s Compensation Committee.

Mr. Quiroz currently serves as CEO Latin America for Prysmian Group, a global leader in the energy and telecommunications cable systems industry. Prior to joining Prysmian Group, Mr. Quiroz served as President, Aptiv Latin America, leading a $5.5 billion automotive technology business with 75,000 employees and 40 locations in Mexico, Central and South America. His previous experience includes leadership roles in various countries at automotive suppliers Tenneco, Edscha AG and Continental AG, as well as home appliance manufacturer Whirlpool.

“Now that more than half of IDEX revenue comes from outside the United States, we look forward to the perspective and insight that Alejandro will bring based on his significant experience leading international manufacturing organizations,” said IDEX Chief Executive Officer and President Eric D. Ashleman. “He has a strong track record of leveraging applied technologies into long-term competitive advantage within a variety of industries and geographies and will be an ideal fit for IDEX.”

Mr. Quiroz holds a Master of Business Administration degree from the University of Michigan Ross School of Business, and a Bachelor of Science degree in Mechanical Engineering from Universidad de las Americas-Puebla. He is a member of the US-Mexico Foundation and the Latino Corporate Directors Association.

“Alejandro has deep current business experience in markets all over the world, which will bring great value to our board. He will be an excellent addition to an already strong Board of Directors,” said William M. Cook, Non-Executive Chairman of the Board.

About IDEX

IDEX (NYSE: IEX) makes thousands of products and mission-critical components that improve everyday life all around you. If you enjoy chocolate, it quite possibly passed through a Viking® internal gear pump at the candy factory. If you were ever in a car accident, emergency workers may have used the Hurst Jaws of Life® rescue tool to save your life. If your doctor ordered a DNA test to predict your risk of disease or determine a course of treatment, the lab may have used equipment containing components made by IDEX Health & Science. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call over 45 diverse businesses around the world part of the IDEX family. With more than 7,500


https://cdn.kscope.io/3b7cba8c930a9ba618524f2b9bd7e2f6-image_0.jpg

employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with nearly $2.8 billion in annual sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

Contact

Mark Spencer
Vice President, Global Communications
847-457-3793